# Centre tells states to act against unauthorised stem cell therapy

> In an advisory issued on September 16, the ministry said stem cell therapy for autism spectrum disorder (ASD) must remain restricted to duly approved clinical trials.

- Published: 2026-09-17T19:42:26.816Z
- Updated: 2026-09-17T19:42:26.816Z
- 1 source
- Topics: Politics
- Involves: National Medical Commission, Supreme Court judgment of January 30, 2026, The latest advisory (on enforcement by state and district authorities), Union health ministry, advisory issued on September 16, advisory issued on September 5

## How it developed

- 2026-09-17T19:42:26.816Z - Times of India: [Centre tells states to act against unauthorised stem cell therapy](https://timesofindia.indiatimes.com/india/centre-tells-states-to-act-against-unauthorised-stem-cell-therapy/articleshow/134317887.cms)

Read it on FeedAtom: https://www.feedatom.com/stories/centre-tells-states-to-act-against-unauthorised-stem-cell-0jx3e0v2trnh5y7rwjhzzmwvc